Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (5187)	12/24/1997 7:27:00 AM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Cant disagree with opalaprils note, nor fitnich,nor tharos. We are obviously in a downtrend. Duh...... So one must ask some questions. (longterm oriented). Does xoma have the capitial or can obtain the capital at a fair rate to survive? How low can stock go? Can I tolerate it? Will the dow drag it down? I have answered those questions for myself, you should all have your own gameplans. IMO I feel that the ultimate result for the stock price continues to be the progress of bpi products. We do also have a building base of royalty stuff further out. The major question mark is the interm. Perhaps may-june to some meningococcemia news, perhaps 2 years to a p3 trauma result. Lots of other possibilties in between. Whatever the actual value the stock could over-react to the downside, or run up on no news or anticipation of news well in advance. It all comes back to bpi. If bpi products are good it doesnt matter where you bought your stock, if you hold it you should do well. If it doesnt work, its another matter. This process (work,not work) is and will be ongoing, and the stock price will be liable to swing with investor moods and perceptions. The end result will be the same does it work or not? PS_thanks ellen for the timeframe post on updates.